Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device
Launched by BALGRIST UNIVERSITY HOSPITAL · Feb 4, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how exercise affects the heart rates of both pregnant women and their babies. Specifically, it will study the effects of physical activity on fetal heart rate, blood flow, and overall health during pregnancy. The goal is to see how exercise impacts moms who are athletes and to ensure that both they and their babies are safe during physical activity.
To participate in this trial, women need to be healthy, active, and between the ages of 18 and 45. They should be regularly exercising for more than four hours a week and be in the later stages of a single pregnancy (between 28 and 34 weeks). Participants will need to sign a consent form to join. This trial is not yet recruiting, but it will provide important information about how physical activity can be safely monitored in pregnant women, which can help improve the health of both mothers and their babies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Presence of signed informed consent form
- • healthy pregnant active female over the age of 18 years and below 45 years
- • sporting activity \>4h/week on 2 or more weekdays
- • single pregnancy, between 28+0 and 34+0 weeks of pregnancy
- Exclusion Criteria:
- • No signed informed consent form or revocation of consent
- • pre-existing pregnancy complications
About Balgrist University Hospital
Balgrist University Hospital is a leading academic medical center based in Zurich, Switzerland, renowned for its expertise in musculoskeletal health and rehabilitation. As a prominent sponsor of clinical trials, the hospital is dedicated to advancing medical research and improving patient outcomes through innovative studies in orthopedics, neurology, and rehabilitation sciences. With a strong commitment to interdisciplinary collaboration and patient-centered care, Balgrist University Hospital leverages its state-of-the-art facilities and a team of experienced researchers to drive clinical advancements and foster the translation of scientific discoveries into practical therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Johannes Scherr, Prof. Dr. med.
Study Chair
University Centre for Prevention and Sports Medicine, Department of Orthopaedics, Balgrist University Hospital, University of Zurich, Zurich, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported